Dividend18 May 2026, 02:43 pm
Strides Pharma Recommends Final Dividend of ₹5 Per Share
AI Summary
Strides Pharma Science Ltd's board approved the audited financial results for the year ended March 31, 2026, and recommended a final dividend of ₹5 per equity share (50%) for FY26. The record date for dividend eligibility will be fixed and announced later. The dividend payment is subject to shareholder approval and tax deduction, payable within 30 days of AGM approval.
Key Highlights
- Audited financial results (standalone and consolidated) for FY26 approved.
- Final dividend of ₹5 per share (50%) recommended for FY26.
- Record date for dividend to be fixed and intimated in due course.
- Dividend payment subject to shareholder approval and tax deduction.
- Board Meeting commenced at 12:30 hrs IST and concluded at 14:15 hrs IST.
Price Impact
More from STAR